GlassScriptPhysician profile
Michael Arthur Valenti
NPI 1275596017
$521.65
in general payments reported to CMS, 2019-2025
8 companies · $12.13 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.52 · 2020: $125 · 2021: $140 · 2023: $164 · 2024: $68.13 · 2025: $12.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $164 · Food and Beverage: $80.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $163.62 |
| Food and Beverage | $80.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $342.10 | 2020-2023 | Sutab, Suflave |
| Davol INC. | $45.26 | 2020 | |
| Organogenesis INC. | $34.41 | 2019-2024 | |
| Medtronic, INC. | $27.48 | 2021 | |
| Tela Bio, INC. | $26.42 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $19.82 | 2024 | Pico 7, Renasys Touch |
| Redhill Biopharma INC. | $14.03 | 2020 | |
| Phathom Pharmaceuticals, INC. | $12.13 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Valenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.